A survey of Australian general practitioners' hepatitis C knowledge and management 2 years after subsidised direct-acting antiviral therapy became available

Affiliations

• ¹ Disease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, Vic. 3004, Australia.
• ² Faculty of Health, Deakin University, 221 Burwood Highway, Burwood, Vic. 3125, Australia.
• ³ Disease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, Vic. 3004, Australia; and School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road,Melbourne, Vic. 3004, Australia.
• ⁴ Department of Medicine, University of Melbourne, Royal Melbourne Hospital, 300 Grattan Street,Parkville, Vic. 3050, Australia; and WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, 792 Elizabeth Street, Melbourne, Vic. 3000, Australia.
• ⁵ Disease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, Vic. 3004, Australia; and Department of Infectious Diseases, The Alfred and Monash University, Level 2, Burnet Institute, 85 Commercial Road, Melbourne, Vic. 3004, Australia.
• ⁶ Disease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, Vic. 3004, Australia; and School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road,Melbourne, Vic. 3004, Australia; and Department of Infectious Diseases, The Alfred and Monash University, Level 2, Burnet Institute, 85 Commercial Road, Melbourne, Vic. 3004, Australia; and Doherty Institute, 792 Elizabeth Street, Melbourne, Vic. 3000, Australia; and Melbourne School of Population and Global Health, Level 4, 207 Bouverie Street, The University of Melbourne, Vic. 3010, Australia.
• ⁷ Disease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, Vic. 3004, Australia; and Department of Infectious Diseases, Barwon Health, Bellerine Street, Geelong, Vic. 3220, Australia; and Corresponding author. Email: [email protected].